| EGRX |
Eagle Pharmaceuticals, Inc. |
Common Stock, par value $0.001 per share |
6.24% |
$1.53M |
|
811K |
|
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Feb 16, 2025 |
| DRIO |
DarioHealth Corp. |
Common Stock, par value $0.0001 per share |
5.78% |
$1.83M |
|
2.51M |
|
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Feb 27, 2025 |
| NSPR |
InspireMD, Inc. |
Common Stock, par value $0.0001 per share |
5.68% |
$5.83M |
|
2.42M |
|
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Sep 30, 2025 |
| KPRX |
KIORA PHARMACEUTICALS, INC. |
Common Stock, $0.01 par value |
5.3% |
$535K |
|
190K |
|
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Aug 8, 2025 |
| ABEO |
ABEONA THERAPEUTICS INC. |
Common Stock, $0.01 par value |
5.09% |
$13.8M |
|
2.62M |
|
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Sep 29, 2025 |
| DRIO |
DarioHealth Corp. |
Common Stock, par value $0.0001 per share |
4.59% |
$5.33M |
|
316K |
|
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Sep 30, 2025 |
| UNCY |
UNICYCIVE THERAPEUTICS, INC. |
Common Stock, par value $0.001 per share |
2.76% |
$1.59M |
-$2.59M |
3.01M |
-61.9% |
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Dec 19, 2024 |
| SRZN |
Surrozen, Inc./DE |
Common Stock, $0.0001 par value per share |
2.2% |
$862K |
-$1.2M |
73.9K |
-58.2% |
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Mar 31, 2025 |
| SNTI |
Senti Biosciences, Inc. |
Common stock, par value $0.0001 per share |
1.9% |
$1.63M |
$651K |
503K |
+66.7% |
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP |
Mar 31, 2025 |